Value

A Proven Track Record of Value Creation

Since our founding in 2002, we have delivered results for partners of all sizes, across all major therapeutic areas, helping partners achieve over $3 billion in deal value.

Learn more about our track record of value creation through some of these success stories.

Is Your Dose Ready
for Phase 3?

Download our free Model-Informed Drug Development Executive Guide
to learn how clinical pharmacology and pharmacometrics can strengthen dose justification and reduce development risk.